Approval · Notice of Compliance 23337 · 2020
OSPHOS INJECTION: Notice of Compliance 23337
Issued March 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23337
- Date
- March 16, 2020
- Company
- Dechra LtdSkipton, North Yorkshire, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update, Addition of drug product manufacturing sites, Change in packaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OSPHOS INJECTION | 02440776 | Marketed |
Medicinal ingredients
- CLODRONATE DISODIUM TETRAHYDRATE 60 MG per ML